UConn Participating in Novel Clinical Trial for Curbing the Most Common Type of Kidney Inflammation
February 09, 2026
February 09, 2026
STORRS, Connecticut, Feb. 9 -- The University of Connecticut posted the following news:
* * *
UConn Participating in Novel Clinical Trial for Curbing the Most Common Type of Kidney Inflammation
*
Have you ever heard of IgA Nephropathy (IgAN)? Probably not, unless you or your loved one's been diagnosed with this actually most common type of kidney inflammation in the world which also afflicts 200,000 Americans annually.
This k . . .
* * *
UConn Participating in Novel Clinical Trial for Curbing the Most Common Type of Kidney Inflammation
*
Have you ever heard of IgA Nephropathy (IgAN)? Probably not, unless you or your loved one's been diagnosed with this actually most common type of kidney inflammation in the world which also afflicts 200,000 Americans annually.
This k . . .